Aura Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 26-12-2024
- Paid Up Capital ₹ 0.50 M
as on 26-12-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 26-12-2024
- Satisfied Charges ₹ 9.45 M
as on 26-12-2024
- Revenue 13.59%
(FY 2022)
- Profit 3.67%
(FY 2022)
- Ebitda 3.56%
(FY 2022)
- Net Worth 18.35%
(FY 2022)
- Total Assets -6.41%
(FY 2022)
About Aura Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹9.45 M, as per Ministry of Corporate Affairs (MCA) records.
Jashvant Shah, Malav Shah, Gatha Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ2001PLC040107
- Company No.
040107
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aura Nutraceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jashvant Shah  | Director | 16-Oct-2001 | Current |
| Malav Shah | Director | 16-Oct-2001 | Current |
| Gatha Shah | Director | 16-Oct-2001 | Current |
| Shobhnaben Shah | Director | 16-Oct-2001 | Current |
| Arpita Shah | Director | 05-Sep-2009 | Current |
Financial Performance of Aura Nutraceuticals.
Aura Nutraceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.59% increase. The company also saw a slight improvement in profitability, with a 3.67% increase in profit. The company's net worth Soared by an impressive increase of 18.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aura Nutraceuticals?
In 2023, Aura Nutraceuticals had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unjha Pharmaceuticals Private LimitedActive 24 years 2 monthsJashvant Shah, Malav Shah and 2 more are mutual person
- Unjha Life Science Private LimitedActive 10 years 1 month
Malav Shah, Gatha Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 12 Mar 2010 | ₹1.50 Cr | Open |
Sardar Vallabhbhai Sahakari Bank Limited Creation Date: 26 Dec 2006 | ₹7.00 M | Satisfied |
State Bank Of India Creation Date: 24 Mar 2004 | ₹2.45 M | Satisfied |
How Many Employees Work at Aura Nutraceuticals?
Aura Nutraceuticals has a workforce of 46 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aura Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aura Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.